129
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comparative Effects of Ischemic Preconditioning and Iron Chelation in Hepatectomy

, MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD, FACS show all
Pages 261-267 | Received 13 Jun 2015, Accepted 26 Feb 2015, Published online: 13 Aug 2015

REFERENCES

  • Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003;237:860–869.
  • Nagorney DM, van Heerden JA, Ilstrup DM, et al. Primary hepatic malignancy: surgical management and determinants of survival. Surgery. 1989;106:740–748.
  • Agarwal N, Murphy JG, Cayten CG, et al. Blood transfusion increases the risk of infection after trauma. Arch Surg. 1993;128:171–176.
  • Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303–309.
  • Stephenson KR, Steinberg SM, Hughes KS, et al. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg. 1988;208:679–687.
  • Tsao JI, Loftus JP, Nagorney DM, et al. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg. 1994;220:199–205.
  • Smyrniotis V, Kostopanagiotou G, Lolis E, et al. Effects of hepatovenous back flow on ischemic- reperfusion injuries in liver resections with the pringle maneuver. J Am Coll Surg. 2003;197:949–954.
  • Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg. 1994;178:454–458.
  • Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155–158.
  • Gujral JS, Bucci TJ, Farhood A, et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology. 2001;33:397–405.
  • Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289–296.
  • Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–298.
  • Larsen FS, Wendon J. Brain edema in liver failure: basic physiologic principles and management. Liver Transpl. 2002;8:983–989.
  • Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol. 1999;31:771–776.
  • Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136.
  • Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol. 2000;279:G163–G171.
  • Peralta C, Closa D, Xaus C, et al. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology. 1998;28:768–773.
  • Yoshizumi T, Yanaga K, Soejima Y, et al. Amelioration of liver injury by ischaemic preconditioning. Br J Surg. 1998;85:1636–1640.
  • Sindram D, Porte RJ, Hoffman MR, et al. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology. 2000;118:183–191.
  • Peralta C, Closa D, Hotter G, et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996;229:264–270.
  • Yadav SS, Sindram D, Perry DK, et al. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology. 1999;30:1223–1231.
  • Arora AS, Gores GJ. The role of metals in ischemia/reperfusion injury of the liver. Semin Liver Dis. 1996;16:31–38.
  • Galaris D, Barbouti A, Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: the role of antioxidants and iron chelating compounds. Curr Pharm Des. 2006;12:2875–2890.
  • Kostopanagiotou GG, Kalimeris KA, Arkadopoulos NP, et al. Desferrioxamine attenuates minor lung injury following surgical acute liver failure. Eur Respir J. 2009;33:1429–1436.
  • Arkadopoulos N, Vlahakos D, Kostopanagiotou G, et al. Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure. Liver Transpl. 2008;14:1116–1124.
  • Lelli JL, Jr., Pradhan S, Cobb LM. Prevention of postischemic injury in immature intestine by deferoxamine. J Surg Res. 1993;54:34–38.
  • Hernandez LA, Grisham MB, Granger DN. A role for iron in oxidant-mediated ischemic injury to intestinal microvasculature. Am J Physiol. 1987;253:G49–G53.
  • Tokyol C, Yilmaz S, Kahraman A, et al. The effects of desferrioxamine and quercetin on liver injury induced by hepatic ischaemia–reperfusion in rats. Acta Chir Belg. 2006;106:68–72.
  • Park K, Chung KY, Sung SH, et al. Protective effect of desferrioxamine during canine liver transplantation: significance of peritransplant liver biopsy. Transplant Proc. 2003;35:117–119.
  • Nakamura T, Keep RF, Hua Y, et al. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100:672–678.
  • Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 1994;25:1039–1045.
  • Arkadopoulos N, Defterevos G, Nastos C, et al. Development of a porcine model of post-hepatectomy liver failure. J Surg Res. 2011;170:e233–e242.
  • Heurteaux C, Lauritzen I, Widmann C, et al. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A. 1995;92:4666–4670.
  • Matsuyama K, Chiba Y, Ihaya A, et al. Effect of spinal cord preconditioning on paraplegia during cross-clamping of the thoracic aorta. Ann Thorac Surg. 1997;63: 1315–1320.
  • Pang CY, Yang RZ, Zhong A, et al. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 1995;29:782–788.
  • Hotter G, Closa D, Prados M, et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun. 1996;222:27–32.
  • Turman MA, Bates CM. Susceptibility of human proximal tubular cells to hypoxia: effect of hypoxic preconditioning and comparison to glomerular cells. Ren Fail. 1997;19:47–60.
  • Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg. 2003;20: 383–396.
  • Tapuria N, Kumar Y, Habib MM, et al. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury—a review. J Surg Res. 2008;150: 304–330.
  • Hawaleshka A, Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth. 1998;45:670–682.
  • Banga NR, Homer-Vanniasinkam S, Graham A, et al. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg. 2005;92:528–538.
  • Clavien PA, Yadav S, Sindram D, et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155–162.
  • Izuishi K, Tsung A, Hossain MA, et al. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology. 2006;44:573–580.
  • Hu GH, Lu XS. Effect of normothermic liver ischemic preconditioning on the expression of apoptosis-regulating genes C-jun and Bcl-XL in rats. World J Gastroenterol. 2005;11:2579–2582.
  • Li SQ, Liang LJ, Huang JF, et al. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol. 2004;10:2580–2584.
  • Barrier A, Olaya N, Chiappini F, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia–reperfusion. FASEB J. 2005;19:1617–1626.
  • Yamada F, Abe T, Saito T, et al. Ischemic preconditioning enhances regenerative capacity of hepatocytes after prolonged ischemia. Transplant Proc. 2001;33:956.
  • Ishii S, Abe T, Saito T, et al. Effects of preconditioning on ischemia/reperfusion injury of hepatocytes determined by immediate early gene transcription. J Hepatobiliary Pancreat Surg. 2001;8:461–468.
  • Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia–reperfusion in the rat: role of nitric oxide and adenosine. Hepatology. 1997;25:934–937.
  • Hardy KJ, McClure DN, Subwongcharoen S. Ischaemic preconditioning of the liver: a preliminary study. Aust N Z J Surg. 1996;66:707–710.
  • Arkadopoulos N, Kostopanagiotou G, Theodoraki K, et al. Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg. 2009;33:1909–1915.
  • Nuzzo G, Giuliante F, Vellone M, et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl. 2004;10:S53–S57.
  • Azoulay D, Lucidi V, Andreani P, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg. 2006;202: 203–211.
  • Gurusamy KS, Kumar Y, Pamecha V, et al. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev. 2009:CD007629.
  • Sharp FR, Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci. 2004;5:437–448.
  • Li YX, Ding SJ, Xiao L, et al. Desferroxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin. Neurosci Bull. 2008;24:89–95.
  • Omar R, Nomikos I, Piccorelli G, et al. Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut. 1989;30:510–514.
  • Colletti LM, Remick DG, Campbell DA, Jr. Desferal attenuates TNF release following hepatic ischemia/reperfusion. J Surg Res. 1994;57:447–453.
  • Colet JM, Cetiner E, Hedlund BE, et al. Assessment of microvascular integrity in the isolated perfused rat liver by contrast-enhanced MRI. Attenuation of reperfusion injury by conjugated deferoxamine. Magn Reson Med. 1996;36:753–757.
  • Drugas GT, Paidas CN, Yahanda AM, et al. Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion. Circ Shock. 1991;34:278–283.
  • Arkadopoulos N, Nastos C, Kalimeris K, et al. Iron chelation for amelioration of liver ischemia–reperfusion injury. Hemoglobin. 2010;34:265–277.
  • Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor—a in liver ischemia–reperfusion injury. J Invest Surg. 2011;24:178–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.